Leading journals welcome new Editors-in-Chief The visions of Profs. Briganti and Rouprêt in shaping the future of clinical research
By Erika De Groot
More features to the journal Prof. Rouprêt proposed to add the following elements to EUO: 1. Additional special thematic issues not sponsored by the pharmaceutical industry The Editorial Board will define two thematic issues (on top of the six regular issues) per year. These will comprise a mix of open-access original articles (obtained by an open call), and invited systematic reviews. 2. Virtual special issues (VSI) VSI can be created by grouping together articles already published in other issues in a digital issue of the EUO on specific themes. This increases the visibility of the journal (i.e. downloads and citations) when some articles are highlighted and grouped. 3. Editorial enhancements Additional features such as lay summaries, graphical abstracts, infographic creation and dissemination, and highlights will be included. To ensure that the EUO continues to meet high standards and publishes the most relevant research, Prof. Rouprêt stated that the journal should attract data from pivotal research projects. “Although the main results from a large phase III clinical trial may naturally go to journals such as the New England Journal of Medicine or Lancet Oncology, the EUO
Authorities in their respective specialties and prize winners of various accolades, Prof. Alberto Briganti (IT) and Prof. Morgan Rouprêt (FR) have taken the mantle of editors-in-chief (EICs) of the prestigious journals European Urology (EU) and European Urology Oncology (EUO), respectively. These journals are part of a family of journals published by Elsevier which also include European Urology Focus and European Urology Open Science .
Read on to get to know the EICs, their aspirations, and the challenges they anticipate in their new roles.
Prof. Briganti takes the lead This June, Prof. Briganti will succeed Prof. James Catto (GB), who has led the EU journal and overseen its family of journals since 2013. Both will collaborate until the end of next year assuring a smooth and solid transition. Prof. Briganti is a Full Professor of Urology at the Vita-Salute San Raffaele University in Milan, Italy. Author of more than 1,200 scientific works published in international peer-reviewed journals, Prof. Briganti’s main research interests include prostate cancer and genitourinary (GU) malignancies. Since 2017, Prof. Briganti has been the EIC of EUO, a sister journal devoted to the study of GU malignancies. He is also a reviewer of numerous scientific journals in urology and oncology. “The main plans for the EU journal will include maintaining the highest possible level of scientific quality while improving dissemination beyond the boundaries of urology.” Throughout his career, Prof. Briganti received numerous accolades such as the EAU Crystal Matula Award, which is a coveted prize given to young promising urologists who have the potential to be future leaders in academic urology. “The designation as editor-in-chief of this prestigious journal provides me with a great sense of professional satisfaction. To accede to this function is a privilege; I aspire to further contribute to the urological scientific community,” stated Prof. Briganti. Tasks and duties Prof. Briganti’s core responsibilities as EIC will include: • Ensuring that published papers in the journal reflect the full scope of urology practice and meet highest scientific standards covering the latest advances Thanks to the precious works of all editors, the EU journal became one of the leading journals in the field of urology which covers the entire spectrum of all urological diseases. However, there is a continuous need to attract high quality research and maintain the high scientific profile of the journal. For these aims, the EU journal will focus on reinforcing collaborations with all major scientific societies and journals, key opinion leaders, scientific and patient groups to maintain stellar scientific quality content and reach all different stakeholders. Prof. Briganti said, “Journals should be more accessible not only to multidisciplinary professionals, but also to lay audiences who can reap the benefits from research especially in the field of urology.” • Developing new initiatives to keep the journal at the forefront of urological research and technology To broaden the journal’s readership, there will be a series of initiatives aimed at introducing new formats of papers; implementing new ways of science dissemination; collaborating with all sections and offices of the EAU; expanding editorial fellowship programmes and educational activities. All of these aims can be achieved by a structural change in the way journals are considered and perceived, which should then shift from a passive to an active practice changing tool.
New EIC of the EU journal, Prof. Briganti
Prof. Rouprêt to lead the EUO journal
• Coordinating the activities of all EAU journals “The EU journal will maintain the lead in coordinating the activities among all four journals as excellently done by Prof. Catto. All EAU journals will work closely together to maintain a tight link and launch common initiatives to ensure that high quality science and contributions will stay within the EAU journals,” said Prof. Briganti. Plans for the journal “The main plans for the EU journal will include maintaining the highest possible level of scientific quality while improving dissemination beyond the boundaries of urology. These will be achieved through a series of novel initiatives aimed at improving the content dissemination within the entire scientific community; expanding access to contents; introducing new formats of online education; implementing publication formats; and fostering the importance of inclusion and diversity,” stated Prof. Briganti. He added that the journal will reinforce its collaboration not only with all EAU sections and offices but also with different scientific groups, journals and societies. These collaborations will create a new and successful platform aimed at increasing the journal’s impact on the urological and non-urological communities. About the EU journal Since its inception in 1975, the EU journal publishes peer-reviewed original articles, reviews, and opinion-piece editorials on a wide range of urological problems on a monthly basis. The EU has a current Impact Factor (IF) of 24.344 making it the leading journal in the field. EUO welcomes Prof. Rouprêt With an equally steadfast dedication to urology and a fellow EAU Crystal Matula Award recipient as well, Prof. Rouprêt will take on the EIC role for the EUO journal as successor to Prof. Briganti. To date, the EUO is ranked 1st in GU cancer journals, 3rd in urology, 9/90 (Q1) in Urology & Nephrology (code ZA), and 42/246 (Q1) in Oncology (code DM). “We aim to further boost EUO’s content quality and scientific rigour, broaden the readership, and address the needs of our specialty. We will incorporate measures demonstrating the journal's reach also beyond the IF.” stated Prof. Rouprêt. “The EUO journal aspires to forge links and attract scientific data from all over the world.” According to Prof. Rouprêt, clinical research is the heart of the EUO reactor. He stated that without research, there are no publications and no evolution of the EAU Guidelines as well. He said, “In practice, urologists are already investigators and implementors of clinical or fundamental research to varying degrees.” Prof. Rouprêt stated that the first step is to further stimulate the EAU's onco-urological network, then boost the global onco-urological network beyond the borders of EAU. “The future of clinical research in oncology lies in the extension of EUO's collaboration with identified research networks. The EUO Editorial Board must network to solicit systematic reviews, position papers, or consensus papers.”
supports the pursuit of a multidisciplinary approach by delivering high quality science and research in GU malignancies.” Journals on socials Social media helps the journals become vehicles that provide dynamic, accessible, and reliable scientific information. Stay updated on their latest publications via their Twitter, Facebook, and LinkedIn accounts. For more information on the journals, please visit
www.europeanurology.com/ and euoncology.europeanurology.com/ .
Editorial Board must be in permanent contact with key investigators and groups in clinical research in GU oncology. This is to draw in the results of the ancillary studies of large therapeutic trials in the field of GU cancer, or the publication of the post hoc analysis into the EUO.” said Prof. Rouprêt. The EUO journal aspires to forge links and attract scientific data from all over the world. If the English language becomes a challenge, the journal aim to offer solutions so that the language barrier will not hinder submissions to the EUO. Major challenges facing the field of urology today According to Prof. Rouprêt, the field of GU malignancies is extremely broad and cancer management requires complex, almost encyclopaedic know-how, and constantly evolving medical and surgical knowledge. He stated, “In recent years, we have seen a revolution in the management of GU cancers which involves diverse disciplines. None of the advances would have occurred without close collaboration between different specialists and health professionals. Nowadays, such collaboration represents one of the pillars of modern treatment of cancer patients and increasingly provides individualised pathways of care to improve patient survival and quality of life. It is in this spirit that the EUO
It runs in the family Our family of journals— European Urology, European Urology Focus, European Urology Oncology and European Urology Open Science —share a passion for urology, an unending commitment to patients, a dedication to multi-disciplinary science, and a continuous focus on quality. — Welcome to our family.
europeanurology.com
euoncology.europeanurology.com
Listed in PubMed
eu-focus.europeanurology.com
eu-openscience.europeanurology.com
Indexed in PubMed
European Urology Today
April/May 2023
15
Powered by FlippingBook